Artios Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
19 déc. 2024 08h00 HE
|
Artios Pharma
CAMBRIDGE, United Kingdom and NEW YORK, December 19, 2024 – Artios Pharma Limited (“Artios”), a clinical-stage biotech company led by pioneers of DNA damage response (“DDR”) drug development, today...
invIOs to present progress across oncology pipeline during JP Morgan Week 2025
16 déc. 2024 09h00 HE
|
invIOs GmbH
VIENNA, Dec. 16, 2024 (GLOBE NEWSWIRE) -- invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, will be participating in JP Morgan week activities in...
CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week
12 déc. 2024 07h00 HE
|
CytoSorbents
CytoSorbents Is Scheduling In-Person Investor Meetings During the JP Morgan Healthcare Conference from Jan 13-15, 2025 in San Francisco.
Inaugural Pre-JPM Partnering Week to Wrap Up 2024, Prepare for 2025
29 août 2024 07h30 HE
|
Big4Bio
New life science partnering conference to debut that prepares and helps industry dealmakers and stakeholders for the JP Morgan Healthcare Conference week
BioNTech stellt strategische Prioritäten für 2024 auf der 42. jährlichen J.P. Morgan Healthcare-Konferenz vor
09 janv. 2024 06h45 HE
|
BioNTech SE
BioNTech rechnet mit zehn oder mehr laufenden potenziell zulassungsrelevanten Studien bis Ende 2024Der Aufbau kommerzieller Kapazitäten zur Vorbereitung auf Produkteinführungen soll Ende 2025...
BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference
09 janv. 2024 06h45 HE
|
BioNTech SE
Plans to have ten or more potentially registrational trials by the end of 2024 Preparing to be commercial-ready by the end of 2025 Ended 2023 with approximately €17.5 billion (unaudited) in cash, cash...
Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
08 janv. 2024 10h59 HE
|
Recursion Pharmaceuticals
SAN FRANCISCO, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today presented a demonstration...
Citeline to Share Exclusive Insights from 42nd Annual J.P. Morgan Healthcare Conference
08 janv. 2024 09h00 HE
|
Citeline
Citeline, a Norstella company, will provide exclusive access, including daily insights, to the 42nd Annual J.P. Morgan Healthcare Conference Jan. 8-11.
Tiziana Life Sciences to Present at Biotech Showcase Conference in San Francisco, January 8-10, 2024
05 janv. 2024 09h30 HE
|
Tiziana Life Sciences Ltd.
Tiziana Life Sciences to Present at Biotech Showcase Conference in San Francisco, January 8-10, 2024
OKYO Pharma to Present at the Biotech Showcase Conference in San Francisco, January 8-10, 2024
05 janv. 2024 09h30 HE
|
OKYO Pharma LTD
OKYO Pharma to Present at the Biotech Showcase Conference in San Francisco, January 8-10, 2024